Pediatric liver transplantation

Seminars in Pediatric Surgery

Volumn 15, Issue 3, 2006, Pages 218-227

  Tiao, Gregory M ^a   Alonso, Maria H ^a   Ryckman, Frederick C ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Biliary atresia; Chronic immunosuppression; Fulminant liver failure; Hepatoblastoma; Pediatric liver transplantation; Tyrosinemia

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VACCINE;

ARTICLE; ATHEROSCLEROSIS; AWARENESS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DONOR; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MEDICAL SPECIALIST; METABOLIC DISORDER; OUTCOME ASSESSMENT; PEDIATRICIAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; SURVIVAL; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GRAFT SURVIVAL; HUMANS; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33745497538     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2006.03.008     Document Type: Article

References (73)

1. Kasai M., Mochizuki I., Ohkohchi N., et al. Surgical limitation for biliary atresia. indication for liver transplantation. J Pediatr Surg 24 (1989) 851-854
2. Ryckman F., Fisher R., Pedersen S., et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 28 (1993) 382-386
3. Nio M., Ohi R., Hayashi Y., et al. Current status of 21 patients who have survived more than 20 years since undergoing surgery for biliary atresia. J Pediatr Surg 31 (1996) 381-384
4. Altman R.P., Lilly J.R., Greenfeld J., et al. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia. twenty-five years of experience from two centers. Ann Surg 226 (1997) 348-353 discussion 353-5.
5. Otte J.B., de Ville de Goyet J., Reding R., et al. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation. a review. Hepatology 20 (1994) 41S-48S
6. Cardona J., Houssin D., Gauthier F., et al. Liver transplantation in children with Alagille syndrome-a study of twelve cases. Transplantation 60 (1995) 339-342
7. Hoffenberg E.J., Narkewicz M.R., Sondheimer J.M., et al. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 127 (1995) 220-224
8. Tzakis A.G., Reyes J., Tepetes K., et al. Liver transplantation for Alagille's syndrome. Arch Surg 128 (1993) 337-339
9. Ryckman F.C., and Alonso M.H. Transplantation for hepatic malignancy in children. In: Busuttil R.W., and Klintmalm G. (Eds). Transplanatation of the Liver (1996), WB Sanders, Philadelphia, PA 216-226
10. McBride K.L., Miller G., Carter S., et al. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics 114 (2004) e523-e526
11. Morioka D., Kasahara M., Takada Y., et al. Current role of liver transplantation for the treatment of urea cycle disorders. a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transplant 11 (2005) 1332-1342
12. Flynn D.M., Mohan N., McKiernan P., et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 88 (2003) F124-F127
13. Rodrigues F., Kallas M., Nash R., et al. Neonatal hemochromatosis - medical treatment vs. Transplantation. the king's experience. Liver Transplant 11 (2005) 1417-1424
14. McClean P., and Davison S.M. Neonatal liver failure. Semin Neonatol 8 (2003) 393-401
15. Dhawan A., Cheeseman P., and Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr Transplant 8 (2004) 584-588
16. Kondrup J., Almdal T., Vilstrup H., and Tygstrup N. High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 15 (1992) 669-676
17. Singer A.L., Olthoff K.M., Kim H., et al. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 234 (2001) 418-424
18. Pimpalwar A.P., Sharif K., Ramani P., et al. Strategy for hepatoblastoma management. Transplant versus nontransplant surgery. J Pediatr Surg 37 (2002) 240-245
19. Srinivasan P., McCall J., Pritchard J., et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 74 (2002) 652-655
20. Molmenti E.P., Nagata D., Roden J., et al. Liver transplantation for hepatoblastoma in the pediatric population. Transplant Proc 33 (2001) 1749
21. Tiao G.M., Bobey N., Allen S., et al. The current management of hepatoblastoma. a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146 (2005) 204-211
22. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110 (1991) 726-734 discussion 734-35.
23. Tagge E.P., Tagge D.U., Reyes J., et al. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma. impact on survival. J Pediatr Surg 27 (1992) 292-296 discussion 297.
24. Freeman Jr. R.B., and Edwards E.B. Liver transplant waiting time does not correlate with waiting list mortality. implications for liver allocation policy. Liver Transplant 6 (2000) 543-552
25. Organ Procurement and Transplantation Network-HRSA. Final rule with comment period. Fed Regist 63 (1998) 16296-16338
26. McDiarmid S.V., Merion R.M., Dykstra D.M., and Harper A.M. Selection of pediatric candidates under the PELD system. Liver Transplant 10 10, suppl 2 (2004) S23-S30
27. Bourdeaux C., Tri T.T., Gras J., et al. PELD score and posttransplant outcome in pediatric liver transplantation. a retrospective study of 100 recipients. Transplantation 79 (2005) 1273-1276
28. Freeman Jr. R.B., Wiesner R.H., and Roberts J.P. Improving liver allocation. MELD and PELD. Am J Transplant 4 (2004) 114-131 2004 (suppl 9)
29. Urata K., Kawasaki S., Matsunami H., et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21 (1995) 1317-1321
30. Ozawa K. Living Related Donor Liver Transplantation (1994), Kargers, Basel 58-60
31. Higashiyama H., Yamaguchi T., Mori K., et al. Graft size assessment by preoperative computed tomography in living related partial liver transplantation. Br J Surg 80 (1993) 489-492
32. Yersiz H., Renz J.F., Farmer D.G., et al. One hundred in situ split-liver transplantations. a single-center experience. Ann Surg 238 (2003) 496-505 discussion 506-7.
33. Morimoto T., Ichimiya M., Tanaka A., et al. Guidelines for donor selection and an overview of the donor operation in living related liver transplantation. Transplant Int 9 (1996) 208-213
34. McDiarmid S.V., Davies D.B., and Edwards E.B. Improved graft survival of pediatric liver recipients transplanted with pediatric-aged liver donors. Transplantation 70 (2000) 1283-1291
35. Emre S., Soejima Y., Altaca G., et al. Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transplant 7 (2001) 41-47
36. Yasutomi M., Harmsmen S., Innocenti F., et al. Outcome of the use of pediatric donor livers in adult recipients. Liver Transplant 7 (2001) 38-40
37. Broelsch C.E., Emond J.C., Whitington P.F., et al. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212 (1990) 368-375 discussion 375-7.
38. Ryckman F.C., Flake A.W., Fisher R.A., et al. Segmental orthotopic hepatic transplantation as a means to improve patient survival and diminish waiting-list mortality. J Pediatr Surg 26 (1991) 422-427 discussion 427-8.
39. Renz J.F., Yersiz H., Reichert P.R., et al. Split-liver transplantation. a review. Am J Transplant 3 (2003) 1323-1335
40. Ryckman F.C., Fisher R.A., Pedersen S.H., and Balistreri W.F. Liver transplantation in children. Semin Pediatr Surg 1 (1992) 162-172
41. Otte J.B., de Ville de Goyet J., Sokal E., et al. Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg 211 (1990) 146-157
42. Inomoto T., Nishizawa F., Sasaki H., et al. Experiences of 120 microsurgical reconstructions of hepatic artery in living related liver transplantation. Surgery 119 (1996) 20-26
43. Burdelski M.M., and Rogiers X. What lessons have we learned in pediatric liver transplantation?. J Hepatol 42 (2005) 28-33
44. Reding R., Webber S.A., and Fine R. Getting rid of steroids in pediatric solid-organ transplantation?. Pediatr Transplant 8 (2004) 526-530
45. Langnas A.N., Marujo W., Stratta R.J., et al. Hepatic allograft rescue following arterial thrombosis. Role of urgent revascularization. Transplantation 51 (1991) 86-90
46. Ueda M., Egawa H., Ogawa K., et al. Portal vein complications in the long-term course after pediatric living donor liver transplantation. Transplant Proc 37 (2005) 1138-1140
47. Heffron T.G., Emond J.C., Whitington P.F., et al. Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation 53 (1992) 391-395
48. Peclet M.H., Ryckman F.C., Pedersen S.H., et al. The spectrum of bile duct complications in pediatric liver transplantation. J Pediatr Surg 29 (1994) 214-219 discussion 219-20.
49. Snover D.C., Sibley R.K., Freese D.K., et al. Orthotopic liver transplantation. a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 4 (1984) 1212-1222
50. Mor E., Solomon H., Gibbs J.F., et al. Acute cellular rejection following liver transplantation. clinical pathologic features and effect on outcome. Semin Liver Dis 12 (1992) 28-40
51. Adams D.H., and Neuberger J.M. Treatment of acute rejection. Semin Liver Dis 12 (1992) 80-88
52. Ryckman F.C., Schroeder T., and Pedersen S. Use of monoclonal antibody immunosuppressive therapy in pediatric renal and liver transplantation. Clin Transplant 5 (1991) 186-190
53. Freese D.K., Snover D.C., Sharp H.L., et al. Chronic rejection after liver transplantation. a study of clinical, histopathological and immunological features. Hepatology 13 (1991) 882-891
54. Ludwig J., Wiesner R.H., Batts K.P., et al. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7 (1987) 476-483
55. Wiesner R.H., Hermans P.E., Rakela J., et al. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45 (1988) 570-574
56. Singh N., Carrigan D.R., Gayowski T., and Marino I.R. Human herpesvirus-6 infection in liver transplant recipients. documentation of pathogenicity. Transplantation 64 (1997) 674-678
57. Patel R., Snydman D.R., Rubin R.H., et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 61 (1996) 1279-1289
58. Fox A.S., Tolpin M.D., Baker A.L., et al. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis 157 (1988) 383-385
59. Darenkov I.A., Marcarelli M.A., Basadonna G.P., et al. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 64 (1997) 848-852
60. Smets F., and Sokal E.M. Lymphoproliferation in children after liver transplantation. J Pediatr Gastroenterol Nutr 34 (2002) 499-505
61. Guthery S.L., Heubi J.E., Bucuvalas J.C., et al. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation 75 (2003) 987-993
62. Penn I. Post-transplant malignancy. the role of immunosuppression. Drug Saf 23 (2000) 101-113
63. Hanto D.W., Frizzera G., Gajl-Peczalska K.J., and Simmons R.L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39 (1985) 461-472
64. Holmes R.D., and Sokol R.J. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 6 (2002) 456-464
65. Holmes R.D., Orban-Eller K., Karrer F.R., et al. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients. 56-month follow up and outcome. Transplantation 74 (2002) 367-372
66. Orjuela M., Gross T.G., Cheung Y.K., et al. A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation. Clin Cancer Res 9 (2003) 39450S-39452S
67. Gross T.G. Low-dose chemotherapy for children with post-transplant lymphoproliferative disease. Recent Results Cancer Res 159 (2002) 96-103
68. Studies of Pediatric Liver Transplantation (SPLIT) 6 (2004) Annual Report, 1-6.27.
69. Sokal E.M., Veyckemans F., de Ville de Goyet J., et al. Liver transplantation in children less than 1 year of age. J Pediatr 117 (1990) 205-210
70. Lozanov J., Millis J.M., Anand R., and Group T.S.R. Surgical outcomes in primary pediatric liver transplantation:SPLIT database report - Abstract #1453. American Transplant Congress (2005) Seattle, WA. (abstr)
71. Deshpande R.R., Bowles M.J., Vilca-Melendez H., et al. Results of split liver transplantation in children. Ann Surg 236 (2002) 248-253
72. Kim J.S., Broering D.C., Tustas R.Y., et al. Split liver transplantation. past, present and future. Pediatr Transplant 8 (2004) 644-648
73. Busuttil R.W., Farmer D.G., Yersiz H., et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. a single-center experience. Ann Surg 241 (2005) 905-918